home All News open_in_new Full Article

U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene

SAN CARLOS, Calif. — BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced that the U.S. Patent and Trademark Office (USPTO) rendered a Final Written Decision invalidating all claims of Pharmacyclics LLC’s (Pharmacyclics) U.S. Patent No. 11,672,803 (the ‘803 patent) […]


today 20 h. ago attach_file Economics

attach_file Events
attach_file Events
attach_file Culture
attach_file Other
attach_file Culture
attach_file Other
attach_file Events
attach_file Events
attach_file Politics
attach_file Other
attach_file Other
attach_file Events
attach_file Events
attach_file Economics
attach_file Economics
attach_file Other
attach_file Events
attach_file Events
attach_file Events
attach_file Other


ID: 2628686628
Add Watch Country

arrow_drop_down